| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $847.1M | +13.3% |
| Cost of Revenue | $311.9M | +14.6% |
| Gross Profit | $535.2M | +12.6% |
| R&D Expense | $79.4M | -24.1% |
| SG&A Expense | $449.7M | +18.9% |
| Operating Income | $6.1M | +181.1% |
| Pre-tax Income | $3.9M | +137.1% |
| Income Tax | $5.9M | +144.9% |
| Net Income | -$2.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.9M | +17.6% |
| Accounts Receivable | $203.4M | +51.8% |
| Inventory | $334.0M | +26.8% |
| Current Assets | $755.7M | +10.9% |
| Total Assets | $1.37B | +10.2% |
| Current Liabilities | $144.9M | +17.6% |
| Total Liabilities | $372.0M | +28.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.7M | -685.8% |
| Capital Expenditures | $19.3M | -8.9% |
| Investing Cash Flow | $54.8M | +352.1% |
| Financing Cash Flow | $11.6M | +1290.2% |
| Free Cash Flow | -$75.0M | -541.9% |
| -137.9% |
| EPS (Basic) | -$0.05 | -135.7% |
| EPS (Diluted) | -$0.05 | -135.7% |
| Stockholders' Equity |
| $998.9M |
| +4.7% |